Huasaibio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Huasaibio General Information

Description

Developer of cell therapy drugs designed to advance the treatment of solid tumours through tumour-infiltrating lymphocyte therapies. The company offers proprietary TIL cell therapy candidates, streamlined cell manufacturing processes, and clinical-stage immunotherapy development capabilities, enabling oncology patients and healthcare providers to access targeted cellular treatments with improved treatment accessibility and therapeutic potential.

Contact Information

Website
www.huasaibiomed.com
Formerly Known As
Qingdao Huasaiboman Medical Cell Biology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1st Floor, Building 7, Phase V, Heda Pharmaceutical Valley
  • Number 1160 Weiken Street, Qiantang District
  • Hangzhou, Zhejiang 900000
  • China
+86 400
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1st Floor, Building 7, Phase V, Heda Pharmaceutical Valley
  • Number 1160 Weiken Street, Qiantang District
  • Hangzhou, Zhejiang 900000
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huasaibio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 14-Aug-2026 Completed Generating Revenue
3. Later Stage VC (Series B) 12-Apr-2026 Completed Generating Revenue
2. Early Stage VC (Series A) 27-Dec-2023 $3.13M Completed Generating Revenue
1. Early Stage VC 21-Nov-2021 $3.13M $3.13M Completed Generating Revenue
To view Huasaibio’s complete valuation and funding history, request access »

Huasaibio Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Huasaibio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026057019-A1 Culture process for tumor-infiltrating lymphocyte Pending 14-Sep-2024
WO-2026007776-A1 Engineered til cell with enhanced sustained killing capacity and use thereof Pending 05-Jul-2024
WO-2025148790-A1 Engineered til cell having improved tumor recognition and killing capability and use thereof Inactive 08-Jan-2024
WO-2025130934-A1 Engineered til expressing membrane-bound il-15 fusion protein and use thereof Inactive 19-Dec-2023
US-20240418725-A1 Method for detecting and isolating cell population co-expressing cd45 and epcam and use thereof Pending 24-Feb-2022 G01N33/5759
To view Huasaibio’s complete patent history, request access »

Huasaibio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Huasaibio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Heda Ventures Venture Capital Minority
Bei'an Holding Corporation Minority
Pine Venture Capital Growth/Expansion Minority
Qingdao Letong Hechuang Equity Investment Growth/Expansion Minority
ASB Ventures Venture Capital Minority
To view Huasaibio’s complete investors history, request access »

Ready to get started?

Request a free trial

Huasaibio FAQs

  • When was Huasaibio founded?

    Huasaibio was founded in 2019.

  • Where is Huasaibio headquartered?

    Huasaibio is headquartered in Hangzhou, China.

  • What is the size of Huasaibio?

    Huasaibio has 44 total employees.

  • What industry is Huasaibio in?

    Huasaibio’s primary industry is Drug Discovery.

  • Is Huasaibio a private or public company?

    Huasaibio is a Private company.

  • What is Huasaibio’s current revenue?

    The current revenue for Huasaibio is .

  • How much funding has Huasaibio raised over time?

    Huasaibio has raised $3.13M.

  • Who are Huasaibio’s investors?

    Heda Ventures, Bei'an Holding, Pine Venture Capital, Qingdao Letong Hechuang Equity Investment, and ASB Ventures have invested in Huasaibio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process